Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel DiseaseRemi Mahmoud, Bas Oldenburg, Maurice Lutgens et al.|Clinical Gastroenterology and Hepatology|2022Cited by 18
Tofacitinib for the treatment of chronic pouchitis: A pilot studyDjuna de Jong, Marjolijn Duijvestein, Rogier Goetgebuer et al.|United European Gastroenterology Journal|2025Cited by 7
DOP70 Anti-TNF withdrawal according to a risk-stratified protocol does not reduce the risk of relapse in patients with Inflammatory Bowel Disease in endoscopic remission: A prospective studyRemi Mahmoud, Bas Oldenburg, Edo Savelkoul et al.|Journal of Crohn s and Colitis|2022Cited by 0
Mo1539: ANTI-TNF WITHDRAWAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN ENDOSCOPIC REMISSION: A PROSPECTIVE STUDYRemi Mahmoud, Bas Oldenburg, Edo Savelkoul et al.|Gastroenterology|2022Cited by 0